The dynamic impact of location and resection on the glioma CSF proteome.

Autor: Riviere-Cazaux C, Graser CJ, Warrington AE, Hoplin MD, Andersen KM, Malik N, Palmer EA, Carlstrom LP, Dasari S, Munoz-Casabella A, Ikram S, Ghadimi K, Himes BT, Jusue-Torres I, Sarkaria JN, Meyer FB, Van Gompel JJ, Kizilbash SH, Sener U, Michor F, Campian JL, Parney IF, Burns TC

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2024 May 16. Date of Electronic Publication: 2024 May 16.

Cerebrospinal fluid 2-hydroxyglutarate as a monitoring biomarker for IDH-mutant gliomas.

Autor: Riviere-Cazaux C; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Lacey JM; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Carlstrom LP; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Laxen WJ; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Munoz-Casabella A; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Hoplin MD; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Ikram S; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Zubair AB; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Andersen KM; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Warrington AE; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Decker PA; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Kaufmann TJ; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Campian JL; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Eckel-Passow JE; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Kizilbash SH; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Tortorelli S; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA., Burns TC; Departments of Neurological Surgery, Laboratory Medicine and Pathology, Neurology, Quantiative Health Sciences, Radiology, and Oncology, Mayo Clinic, Rochester, Minnesota, USA.

Publikováno v: Neuro-oncology advances [Neurooncol Adv] 2023 May 11; Vol. 5 (1), pp. vdad061. Date of Electronic Publication: 2023 May 11 (Print Publication: 2023).